WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 18 fonti

Promising new treatment for pancreatic cancer doubles survival rates

A medical breakthrough in the fight against pancreatic cancer is showing promising results after decades of research. The experimental drug, taken once a day, extends patients’ lives by slowing the progression of one of the deadliest cancers. Dr. Rachna Shroff, associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, joins Stephanie Sy for more.

Raccontata dabiopharmadive.commedpagetoday.comnbcnews.comindependent.co.uktheguardian.comdailymail.commirror.co.ukcbsnews.comfortune.comcnn.comdailysabah.cominews.co.uk+6 altre

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
pbs.orgStai leggendo14 h fa

Promising new treatment for pancreatic cancer doubles survival rates

Daraxonrasib doubled pancreatic cancer survival to 13 months versus 6 months, targeting KRAS mutations. With >90% of pancreatic cancers carrying KRAS mutations and applicability to lung and colon tumors, this reshapes precision-oncology investment thesis.

originale
independent.co.uk2 g fa

Experimental pill promises new hope for deadly pancreatic cancer

New research shows a novel pill is helping people with advanced pancreatic cancer live longer

Leggi questa versione → originale
dailymail.com2 g fa

New drug gives extra months of life to pancreatic cancer patients

Daraxonrasib, a once-daily RAS inhibitor targeting the KRAS mutation driving 90% of pancreatic cancers, doubled median survival vs. chemotherapy (12+ months vs. 6.6 months) in a 500-patient trial presented at ASCO 2025. For health-tech and pharma-adjacent orgs, this validates the RAS inhibitor class as a viable therapeutic platform — Revolution Medicine is moving toward regulatory submission in the US, signaling a near-term pipeline shift in oncology treatment standards.

Leggi questa versione → originale
cnn.com1 g fa

Experimental pill promises new hope for deadly pancreatic cancer | CNN

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer.

Leggi questa versione → originale
dailysabah.com1 g fa

Experimental pill offers breakthrough hope in pancreatic cancer fight

Daraxonrasib, a daily oral KRAS inhibitor by Revolution Medicines, nearly doubled median survival in metastatic pancreatic cancer (13.2 vs 6.7 months) in a 500-patient Phase 3 trial, with the FDA fast-tracking review. The drug breaks a decades-long stalemate on KRAS — mutated in 90%+ of pancreatic cases — signaling that the "undruggable" oncology target class is now open, with downstream implications for RAS-driven cancers beyond pancreatic.

Leggi questa versione → originale
cbsnews.com1 g fa

New drug nearly doubles survival rates in some pancreatic cancer patients, study says

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

Leggi questa versione → originale

Timeline cronologica

  1. domenica 31 maggio 2026·biopharmadive.com

    ‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer

    Highly anticipated data presented at ASCO confirmed what’s been heralded as a medical breakthrough against a historically tough-to-treat tumor.

  2. domenica 31 maggio 2026·medpagetoday.com

    'Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival

    RASolute 302 findings herald a new standard of care in previously treated patients

  3. domenica 31 maggio 2026·nbcnews.com

    After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses

    The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.

  4. domenica 31 maggio 2026·independent.co.uk

    Daily pill almost doubles survival time for pancreatic cancer patients in new trial

    Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease

  5. domenica 31 maggio 2026·theguardian.com

    Daily pill can double survival time for world’s deadliest cancer, trial shows

    Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer

  6. domenica 31 maggio 2026·dailymail.com

    New drug gives extra months of life to pancreatic cancer patients

    Doctors today hailed a breakthrough in the fight against pancreatic cancer after a new drug was shown to give patients precious extra months of life.

  7. domenica 31 maggio 2026·independent.co.uk

    Experimental pill promises new hope for deadly pancreatic cancer

    New research shows a novel pill is helping people with advanced pancreatic cancer live longer

  8. domenica 31 maggio 2026·mirror.co.uk

    Cancer breakthrough as new 'game-changing' pill could double survival time

    Prostate cancer patients normally have a devastatingly short life expectancy - but the new daily pill being offered in clinical trials could change that

  9. domenica 31 maggio 2026·independent.co.uk

    Pancreatic cancer breakthrough as pill almost doubles survival time for patients

    Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

  10. domenica 31 maggio 2026·cbsnews.com

    New drug nearly doubles survival rates in some pancreatic cancer patients, study says

    New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

  11. domenica 31 maggio 2026·fortune.com

    Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. 'I actually started crying' | Fortune

    The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for…

  12. domenica 31 maggio 2026·cnn.com

    Experimental pill promises new hope for deadly pancreatic cancer | CNN

    A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…

  13. domenica 31 maggio 2026·dailysabah.com

    Experimental pill offers breakthrough hope in pancreatic cancer fight

    An experimental drug for advanced pancreatic cancer significantly extended survival in a major clinical trial, offering fresh hope for improved treatment...

  14. domenica 31 maggio 2026·inews.co.uk

    Why this new pill for a deadly cancer has doctors excited

    The results of a clinical trial of a new drug could signal a breakthrough in treating pancreatic cancer

  15. domenica 31 maggio 2026·quotidianodelsud.it

    Cancro al pancreas, un nuovo farmaco raddoppia il periodo di sopravvivenza: lo studio - Il Quotidiano del Sud

    2 minuti per la lettura (Adnkronos) – Una pillola, presa ogni giorno, può raddoppiare il periodo di sopravvivenza per i pazienti colpiti da cancro al pancreas. Sono i risultati di…

  16. domenica 31 maggio 2026·pbs.org

    Experimental drug shows promise against deadly pancreatic cancer

    A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types…

  17. lunedì 1 giugno 2026·nature.com

    Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments

    Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumours will be next.

  18. lunedì 1 giugno 2026·sciencealert.com

    Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers

    WASHINGTON (AP) – A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of…

  19. lunedì 1 giugno 2026·benzinga.com

    Revolution Medicines' Pancreatic Cancer Pill Doubles Survival, Cuts Death Risk 60% in Trial As Stock Sits

    Few cancers have proven as difficult to treat as pancreatic cancer, making any sign of a survival breakthrough a major event for both patients and investors.

  20. lunedì 1 giugno 2026·newsbytesapp.com

    This drug can double survival time for pancreatic cancer patients

    A groundbreaking daily pill has been shown to double survival time for patients battling the world's deadliest cancer, marking a major advancement in medical research.